MedPath

Clinical Evaluation and Mechanism of Jianpi Tongluo Jiedu Method in the Treatment of Chronic Atrophic Gastritis

Early Phase 1
Recruiting
Conditions
chronic atrophic gastritis
Registration Number
ITMCTR2023000021
Lead Sponsor
Guang 'anmen Hospital, China academy of Chinese medicine sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1 .18-65 years old ; 2 .in line with Western diagnostic criteria for chronic atrophic gastritis ; 3. In line with the diagnostic criteria of TCM spleen and stomach weakness and stomach collaterals blood stasis syndrome ; 4. Patients volunteered to participate in this project and signed informed consent.

Exclusion Criteria

1 Gastric ulcer, duodenal ulcer or ulcer with bleeding ;
2 patients with moderate to severe dysplasia diagnosed by histopathology ;
3 patients with suspected gastric cancer or other malignant lesions ;
4 patients with a history of gastric surgery ;
5 long-term use of NSAID drugs ;
6 Complicated with primary diseases such as heart, cerebrovascular, liver, kidney, hematopoietic system and psychiatric patients.
7 Pregnant and lactating women
8 allergic constitution or allergic to the test drug.
9 those who participated in other clinical drug experiments in the past month.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pathological changes of mucosa under gastroscope;
Secondary Outcome Measures
NameTimeMethod
Endoscopic mucosal manifestations;tcm symptom score;Overall risk of gastric mucosal carcinogenesis;
© Copyright 2025. All Rights Reserved by MedPath